| Literature DB >> 32634781 |
David G Pfister1, Sharon Spencer2, David Adelstein3, Douglas Adkins4, Yoshimi Anzai5, David M Brizel6, Justine Y Bruce7, Paul M Busse8, Jimmy J Caudell9, Anthony J Cmelak10, A Dimitrios Colevas11, David W Eisele12, Moon Fenton13, Robert L Foote14, Thomas Galloway15, Maura L Gillison16, Robert I Haddad17, Wesley L Hicks18, Ying J Hitchcock5, Antonio Jimeno19, Debra Leizman3, Ellie Maghami20, Loren K Mell21, Bharat B Mittal22, Harlan A Pinto11, John A Ridge15, James W Rocco23, Cristina P Rodriguez24, Jatin P Shah1, Randal S Weber16, Gregory Weinstein25, Matthew Witek7, Frank Worden26, Sue S Yom27, Weining Zhen28, Jennifer L Burns29, Susan D Darlow29.
Abstract
Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This article describes supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers. This article also describes updates to treatment recommendations for patients with very advanced H&N cancers and salivary gland tumors, specifically systemic therapy recommendations.Entities:
Year: 2020 PMID： 32634781 DOI： 10.6004/jnccn.2020.0031
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908